What are you searching for?
Lars Petersen, President & CEO of Fujifilm Diosynth Biotechnologies, discusses supply chain agility, ‘partners for life,’ KojoX and more.
Panting will be responsible for developing and driving a unified strategic roadmap.
Otulfi was approved by the FDA for both subcutaneous and intravenous formulations as a biosimilar to Stelara.
Will increase capacity for liquid, suspension, semi-solid, and suppository drug products.
To expand its Glasgow, UK facility and offers updates on the ongoing expansion to its Albuquerque, NM facility.
Subscribe to Magazine for top news, trends & analysis
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !